The gene that codes for p53 is the most frequently mutated in cancer. Researchers are targeting different parts of its complex pathway to restore its ability to stop cancer.
Articles on Apoptosis
Displaying all articles
A marine sponge from Mauritius has shown potential as the source of compounds that kill liver cancer cells.
Your cells die to keep you alive. Cell death does everything from fighting cancer cells and pathogens to forming your fingers and toes.
COVID-19 causes lung injury and lowers oxygen levels in patients because the SARS-CoV-2 virus attacks cells’ mitochondria. This attack is a throwback to a primitive war between viruses and bacteria.
Coinfections with bacteria can make viral infections even deadlier. Researchers have identified a protein in immune cells that may play a role in fighting both types of pathogens.
A recent lab-stage study finds that preexposure to the proteins used to treat conditions like hemophilia A could help train the immune system to tolerate rather than attack therapies.
The survival of the human body is a fine balancing act between cell growth and cell death. Understanding our cells’ complex “licence to die” could give us new ways to combat disease.
Emerging evidence suggests that prolonged stress exposure can accelerate the ticking rate of an internal cellular clock. By doing so, stress can contribute to faster ageing and body deterioration.
With fall almost upon us, there’s a lot we can learn from the changing season.
A new silver-based compound that is less toxic with fewer side effects could hold the key to crippling cancer.
Chemotherapy is the use of drugs to treat cancer. It is often paired with surgery, radiotherapy and immunotherapy in a cancer treatment plan.
Top contributors
-
Research Assistant Professor in Oral and Craniofacial Sciences, University of Pittsburgh
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Head of department inn the Department of Chemistry, University of Johannesburg
-
Head of the Department of Biochemistry, University of Johannesburg
-
Research Assistant Professor of Immunology, Tufts University
-
Associate Professor, Biochemistry, La Trobe University
-
Postdoctoral Research Fellow, Leibniz Centre for Tropical Marine Research (ZMT)
-
Research scientist, La Trobe University
-
Professor of Pharmaceutical Sciences, University at Buffalo
-
Director of Translational Institute of Medicine (TIME), Queen's University, Ontario
-
Postdoctoral fellow, Tufts University
-
DECRA Fellow, UNSW
-
Ph.D. Candidate in Integrative Systems Biology, University of Pittsburgh